Intellia Therapeutics Inc (NTLA) Insider Trading

Total insider buys:
  • $13,217,886.00
Total insider sells:
  • $277,561,962.62
Most recent insider trade:
  • March 4, 2024
Most active insider trader:
  • John M Leonard
Trader NameDateTitleAmountPriceTypeTotal Value
March 4, 2024EVP2,297$32.99Sell$75,778.03
Jan. 8, 2024EVP2,275$28.87Sell$65,679.25
Jan. 3, 2024CEO19,223$29.46Sell$566,309.58
Jan. 3, 2024EVP5,843$29.46Sell$172,134.78
Jan. 3, 2024CFO5,365$29.46Sell$158,052.90
Oct. 31, 2023Director265$23.90Sell$6,333.50
July 31, 2023Director265$42.33Sell$11,217.45
July 6, 2023Director1,867$39.30Sell$73,373.10
July 3, 2023EVP360$40.51Sell$14,583.60
June 20, 2023EVP5,000$45.00Sell$225,000.00
Jan. 4, 2023CEO6,673$37.21Sell$248,302.33
Jan. 4, 2023CFO2,427$37.21Sell$90,308.67
Jan. 4, 2023EVP2,508$37.21Sell$93,322.68
Jan. 1, 2022CFO1,013$112.24Sell$113,699.12
Jan. 1, 2022EVP1,148$112.25Sell$128,863.00
Jan. 1, 2022CEO2,493$112.25Sell$279,839.25
Nov. 5, 2021EVP2,400$132.72Sell$318,528.00
Oct. 14, 2021EVP2,400$128.44Sell$308,256.00
Oct. 11, 2021Director2,500$119.55Sell$298,875.00
Oct. 5, 2021Director10,000$130.54Sell$1,305,400.00
Sept. 21, 2021EVP2,400$149.81Sell$359,544.00
Sept. 7, 2021CFO3,482$180.12Sell$627,177.84
Sept. 1, 2021CEO44,735$170.00Sell$7,604,950.00
Aug. 31, 2021CFO24,800$160.22Sell$3,973,456.00
Aug. 30, 2021CEO38,804$155.95Sell$6,051,483.80
Aug. 30, 2021EVP97,000$154.83Sell$15,018,510.00
Aug. 19, 2021CEO22,682$151.28Sell$3,431,332.96
Aug. 9, 2021EVP2,400$164.05Sell$393,720.00
Aug. 5, 2021CFO20,000$151.05Sell$3,021,000.00
Aug. 4, 2021EVP26,000$138.24Sell$3,594,240.00
June 28, 2021Director553,376$132.73Sell$73,449,596.48
June 14, 2021Director170,779$87.37Sell$14,920,961.23
June 11, 2021Director30,946$85.23Sell$2,637,527.58
April 28, 2021Director131,926$85.56Sell$11,287,588.56
April 26, 2021Director806$84.93Sell$68,453.58
April 5, 2021Director7,500$82.19Sell$616,425.00
April 1, 2021EVP50,455$82.46Sell$4,160,519.30
April 1, 2021CEO38,209$83.64Sell$3,195,800.76
Feb. 26, 2021Director501,945$60.29Sell$30,262,264.05
Feb. 9, 2021EVP11,489$75.00Sell$861,675.00
Feb. 9, 2021CEO28,043$75.00Sell$2,103,225.00
Feb. 5, 2021CEO22,942$67.66Sell$1,552,255.72
Feb. 3, 2021CEO67,856$72.54Sell$4,922,274.24
Feb. 1, 2021EVP54,659$63.99Sell$3,497,629.41
Feb. 1, 2021CEO109,889$64.00Sell$7,032,896.00
Jan. 5, 2021COO1,377$55.86Sell$76,919.22
Jan. 5, 2021CEO6,239$55.86Sell$348,510.54
Jan. 5, 2021EVP2,078$55.86Sell$116,077.08
Dec. 17, 2020Director88,764$53.55Sell$4,753,312.20
Dec. 1, 2020EVP3,364$38.21Sell$128,538.44
First«1 of 2»Last
  • Insiders are both buying and selling Intellia Therapeutics Inc stock.

  • The insider traders at Intellia Therapeutics Inc are: John M Leonard, Jose E Rivera, Jean Francois Formela, Glenn Goddard, David Lebwohl, Laura Sepp-Lorenzino, Jose E. Rivera, Muna Bhanji, Andrew Schiermeier, Eliana Clark, Institutes For Biomed Novartis, John F Crowley, John M. Leonard, Nessan Bermingham, Caroline Dorsa, Carl L Gordon, Caribou Biosciences, Inc., Bros. Advisors Lp Baker, Venture Fund Ix L.P. Atlas, James Basta, and Perry A Karsen

  • The most active insider trader at Intellia Therapeutics Inc is John M Leonard with 19 trades.

  • Jean Francois Formela has sold the most Intellia Therapeutics Inc stock with a total value of $207,869,472.85.

  • Institutes For Biomed Novartis has bought the most Intellia Therapeutics Inc stock with a total value of $9,999,972.00.

  • The most recent insider trade for Intellia Therapeutics Inc was on March 4, 2024.

  • The single biggest insider buy for Intellia Therapeutics Inc was from Institutes For Biomed Novartis with a total value of $4,999,986.00 on May 11, 2016.

  • The single biggest insider sell for Intellia Therapeutics Inc was from Jean Francois Formela with a total value of $73,449,596.48 on June 28, 2021.